See more : SAMCO Inc. (6387.T) Income Statement Analysis – Financial Results
Complete financial analysis of Dentium CO., LTD (145720.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dentium CO., LTD, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- JPMorgan Elect plc – Managed Income (JPEI.L) Income Statement Analysis – Financial Results
- Ion Beam Applications SA (IBAB.BR) Income Statement Analysis – Financial Results
- Hualan Biological Engineering Inc. (002007.SZ) Income Statement Analysis – Financial Results
- Resolute Mining Limited (RSG.AX) Income Statement Analysis – Financial Results
- Godawari Power & Ispat Limited (GPIL.NS) Income Statement Analysis – Financial Results
Dentium CO., LTD (145720.KS)
About Dentium CO., LTD
Dentium Co.,Ltd. manufactures and sells dental implant products worldwide. Its dental implant systems include superline, implantium, simpleline II, slimline, overdenture system, NR line, and implantium II. The company also provides surgical instruments, such as surgical, drill stopper, sinus, osteotome, trephine bur, prosthetic, planning, restorative, and help kits, as well as harvest drills, sinus elevators, GBR systems, surgical guides, temporary shells, white seals, TN brushes, and guide systems; regeneration products, including bone grafts, membranes, and tissue regeneration products; and digital dentistry products. In addition, it offers lab products; and iCT motors and injections. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. The company was founded in 2000 and is headquartered in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 393.19B | 355.87B | 291.53B | 229.75B | 252.59B | 186.32B | 150.65B | 120.03B | 95.49B | 87.14B | 73.92B | 61.98B | 70.76B |
| Cost of Revenue | 114.35B | 95.19B | 98.38B | 86.95B | 85.01B | 55.54B | 44.03B | 36.75B | 26.78B | 25.63B | 17.43B | 23.41B | 19.59B |
| Gross Profit | 278.84B | 260.68B | 193.15B | 142.80B | 167.58B | 130.77B | 106.62B | 83.29B | 68.71B | 61.51B | 56.50B | 38.57B | 51.17B |
| Gross Profit Ratio | 70.92% | 73.25% | 66.26% | 62.15% | 66.35% | 70.19% | 70.77% | 69.39% | 71.96% | 70.59% | 76.43% | 62.23% | 72.32% |
| Research & Development | 6.87B | 5.63B | 5.45B | 5.02B | 6.51B | 8.40B | 5.25B | 4.68B | 3.84B | 2.46B | 2.39B | 2.17B | 2.59B |
| General & Administrative | 16.00B | 14.34B | 12.82B | 10.75B | 15.46B | 11.06B | 7.31B | 6.10B | 5.37B | 4.72B | 3.19B | 2.51B | 2.43B |
| Selling & Marketing | 48.57B | 42.61B | 45.42B | 29.56B | 37.62B | 27.74B | 20.06B | 13.81B | 13.63B | 12.96B | 10.22B | 8.00B | 8.25B |
| SG&A | 64.57B | 56.95B | 58.24B | 40.30B | 53.08B | 38.80B | 27.37B | 19.91B | 19.00B | 17.68B | 13.41B | 10.51B | 10.69B |
| Other Expenses | 69.12B | 72.36B | 59.30B | 57.88B | 63.32B | 770.63M | -229.17M | -208.45M | 366.04M | 470.20M | -17.94M | 150.35M | 257.99M |
| Operating Expenses | 140.56B | 134.95B | 122.98B | 103.20B | 122.90B | 88.79B | 65.54B | 54.76B | 51.94B | 43.48B | 35.81B | 26.82B | 31.99B |
| Cost & Expenses | 254.96B | 230.14B | 221.36B | 190.15B | 207.91B | 144.33B | 109.57B | 91.50B | 78.71B | 69.11B | 53.24B | 50.23B | 51.58B |
| Interest Income | 1.30B | 683.38M | 333.06M | 198.24M | 416.17M | 391.96M | 238.83M | 190.83M | 196.28M | 144.63M | 164.18M | 276.11M | 403.73M |
| Interest Expense | 7.43B | 6.79B | 6.08B | 8.03B | 5.16B | 1.38B | 423.50M | 961.64M | 1.05B | 631.71M | 391.57M | 229.23M | 654.60M |
| Depreciation & Amortization | 20.88B | 15.79B | 12.81B | 13.64B | 12.11B | 5.23B | 4.89B | 3.94B | 3.53B | 2.66B | 2.14B | 1.98B | 1.75B |
| EBITDA | 162.80B | 140.97B | 93.61B | 47.73B | 50.88B | 48.61B | 45.65B | 31.29B | 20.30B | 21.51B | 23.32B | 12.59B | 21.82B |
| EBITDA Ratio | 41.40% | 40.51% | 32.04% | 21.69% | 23.05% | 26.53% | 27.61% | 26.11% | 23.10% | 26.02% | 30.43% | 20.19% | 31.17% |
| Operating Income | 138.28B | 125.70B | 69.88B | 39.60B | 44.66B | 41.96B | 41.08B | 28.53B | 16.78B | 18.04B | 20.68B | 11.75B | 19.86B |
| Operating Income Ratio | 35.17% | 35.32% | 23.97% | 17.23% | 17.68% | 22.52% | 27.27% | 23.77% | 17.57% | 20.70% | 27.98% | 18.96% | 28.07% |
| Total Other Income/Expenses | -3.80B | -7.31B | -5.99B | -13.54B | -11.05B | -3.56B | -4.87B | -2.14B | -1.39B | -265.68M | -729.32M | -1.37B | -441.92M |
| Income Before Tax | 134.48B | 118.39B | 74.72B | 26.05B | 33.60B | 42.01B | 35.88B | 26.39B | 17.43B | 19.37B | 19.93B | 10.38B | 19.42B |
| Income Before Tax Ratio | 34.20% | 33.27% | 25.63% | 11.34% | 13.30% | 22.55% | 23.82% | 21.98% | 18.25% | 22.22% | 26.96% | 16.75% | 27.44% |
| Income Tax Expense | 37.95B | 32.25B | 19.22B | 3.83B | 19.89B | 7.75B | 5.59B | 6.39B | 2.93B | 3.16B | 5.23B | 2.59B | 5.72B |
| Net Income | 96.52B | 86.07B | 55.48B | 22.54B | 14.79B | 34.25B | 30.07B | 19.79B | 14.48B | 16.14B | 14.77B | 7.41B | 14.14B |
| Net Income Ratio | 24.55% | 24.18% | 19.03% | 9.81% | 5.85% | 18.38% | 19.96% | 16.49% | 15.17% | 18.52% | 19.98% | 11.96% | 19.98% |
| EPS | 11.19K | 9.98K | 6.43K | 2.61K | 1.71K | 3.97K | 3.69K | 3.26K | 2.38K | 2.51K | 1.87K | 782.00 | 1.46K |
| EPS Diluted | 11.19K | 9.98K | 6.43K | 2.59K | 1.70K | 3.97K | 3.69K | 3.26K | 2.38K | 2.51K | 1.87K | 769.00 | 1.43K |
| Weighted Avg Shares Out | 8.62M | 8.62M | 8.62M | 8.62M | 8.62M | 8.62M | 8.16M | 6.08M | 6.08M | 6.79M | 7.88M | 9.48M | 9.70M |
| Weighted Avg Shares Out (Dil) | 8.62M | 8.62M | 8.62M | 8.68M | 8.68M | 8.62M | 8.16M | 6.08M | 6.08M | 6.79M | 7.88M | 9.64M | 9.89M |
Source: https://incomestatements.info
Category: Stock Reports